These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23225811)

  • 21. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement.
    Kim BK; Park YN; Kim DY; Park JY; Chon CY; Han KH; Ahn SH
    Digestion; 2012; 85(3):219-27. PubMed ID: 22414567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
    Heinzow HS; Lenz P; Köhler M; Reinecke F; Ullerich H; Domschke W; Domagk D; Meister T
    World J Gastroenterol; 2012 Oct; 18(37):5211-8. PubMed ID: 23066315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
    Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation.
    Hui AY; Chan HL; Leung NW; Hung LC; Chan FK; Sung JJ
    J Clin Gastroenterol; 2002; 34(5):569-72. PubMed ID: 11960072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
    Schwarzer R; Reiberger T; Mandorfer M; Kivaranovic D; Hametner S; Hametner S; Paternostro R; Scheiner B; Schneeweiss-Friedl J; Trauner M; Schoefl R; Maieron A
    J Gastroenterol; 2020 May; 55(5):533-542. PubMed ID: 31832759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis.
    Su TH; Peng CY; Tseng TC; Yang HC; Liu CJ; Liu CH; Chen PJ; Chen DS; Kao JH
    J Infect Dis; 2020 Feb; 221(4):589-597. PubMed ID: 31574141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EVALUATION OF PROGNOSTIC FACTORS IN DECOMPENSATED LIVER CIRRHOSIS WITH ASCITES AND SPONTANEOUS BACTERIAL PERITONITIS.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(4):1018-24. PubMed ID: 26793843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term course of chronic hepatitis B.
    Di Marco V; Lo Iacono O; Cammà C; Vaccaro A; Giunta M; Martorana G; Fuschi P; Almasio PL; Craxì A
    Hepatology; 1999 Jul; 30(1):257-64. PubMed ID: 10385664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TIPS for management of refractory ascites: response and survival are both unpredictable.
    Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
    Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation.
    Giannelli V; Roux O; Laouénan C; Manchon P; Ausloos F; Bachelet D; Rautou PE; Weiss E; Moreau R; Mebazaa A; Cohen-Solal A; Durand F; Francoz C
    J Hepatol; 2020 Mar; 72(3):463-471. PubMed ID: 31622697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis.
    Chen RC; Cai YJ; Wu JM; Wang XD; Song M; Wang YQ; Zheng MH; Chen YP; Lin Z; Shi KQ
    J Viral Hepat; 2017 Mar; 24(3):238-245. PubMed ID: 27862671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the risk of decompensation by ascites and spontaneous bacterial peritonitis in cirrhosis.
    Dănulescu RM; Stanciu C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):320-6. PubMed ID: 25076694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study.
    Nie Y; Liu LX; Chen T; Zhang Y; Zhu X
    Epidemiol Infect; 2021 Jan; 149():e26. PubMed ID: 33397544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Patients with HBV-Related Decompensated Cirrhosis.
    Wang CJ; Wu JP; Zhou WQ; Mao WL; Huang HB
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.
    Liu K; Choi J; Le A; Yip TC; Wong VW; Chan SL; Chan HL; Nguyen MH; Lim YS; Wong GL
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1037-1048. PubMed ID: 31524304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Virologic Response to Treatment on Short- and Long-term Outcomes of Patients With Chronic Hepatitis B Virus Infection and Decompensated Cirrhosis.
    Jang JW; Choi JY; Kim YS; Yoo JJ; Woo HY; Choi SK; Jun CH; Lee CH; Sohn JH; Tak WY; Lee YR; Han KH
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1954-1963.e3. PubMed ID: 29753085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein-to-albumin ratio is a predictor of hepatitis B virus related decompensated cirrhosis: time-dependent receiver operating characteristics and decision curve analysis.
    Huang SS; Xie DM; Cai YJ; Wu JM; Chen RC; Wang XD; Song M; Zheng MH; Wang YQ; Lin Z; Shi KQ
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):472-480. PubMed ID: 27984322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.